Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Helicobacter pylori cell wall peptidoglycan is a vital structural heteropolymer that provides mechanical strength and maintains the osmotic stability of the bacterium within the harsh gastric environment. It is composed of glycan strands of alternating N-acetylglucosamine and N-acetylmuramic acid residues, which are cross-linked by short peptide chains (Viala et al., 2004, Science, DOI: 10.1126/science.1103471). This structure is essential for the survival and spiral morphology of H. pylori, which is necessary for its motility through the gastric mucus. In a clinical context, the peptidoglycan is a primary target for beta-lactam antibiotics like amoxicillin, which disrupt the cross-linking process, resulting in bacterial death (StatPearls, 2023, 'Amoxicillin'). Beyond its structural role, H. pylori peptidoglycan acts as a potent pathogen-associated molecular pattern (PAMP). Fragments of the peptidoglycan are delivered into host gastric epithelial cells via the Cag type IV secretion system, where they are sensed by the intracellular pattern recognition receptor NOD1 (Chamaillard et al., 2003, Nature Immunology, DOI: 10.1038/ni937). This recognition triggers the NF-kappaB signaling pathway, leading to the production of pro-inflammatory cytokines and contributing to the chronic inflammation associated with gastric ulcers and cancer.
Inhibition of peptidoglycan biosynthesis by binding to penicillin-binding proteins (PBPs), leading to cell wall weakening and osmotic lysis; enzymatic hydrolysis of beta-1,4-glycosidic bonds by lysozyme; activation of host NOD1 receptors by peptidoglycan fragments.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Helicobacter pylori cell wall peptidoglycan (H. pylori PGN).